Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Every AI Agent Needs a Kill Switch: DigiCert Launches AI Trust Manager

September 15, 2026

The Royal Society of Canada Announces its 2026 Award Winners

September 15, 2026

OpenEye and CENTEGIX Integrate Live Video and Emergency Alerts to Accelerate Incident Response

September 15, 2026

ClassOne Technology Secures Multi-System Follow-on Orders from Top Photonics Manufacturers for High-Volume 6-inch InP Gold Plating

September 15, 2026

UNSW Delegation Visits COFE+ 7th-Generation Robotic Café in Shanghai, Exploring the Future of AI-Powered Coffee Retail

September 15, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Brain Tumor Diagnosis and Treatment Business/Research Report 2024-2030: Increasing Focus on Clinical Trials and Approvals for Novel Therapeutics to Influence Future Market Prospects
Press Release

Brain Tumor Diagnosis and Treatment Business/Research Report 2024-2030: Increasing Focus on Clinical Trials and Approvals for Novel Therapeutics to Influence Future Market Prospects

By News RoomDecember 3, 20243 Mins Read
Brain Tumor Diagnosis and Treatment Business/Research Report 2024-2030: Increasing Focus on Clinical Trials and Approvals for Novel Therapeutics to Influence Future Market Prospects
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) — The “Brain Tumor Diagnosis and Treatment – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The global market for Brain Tumor Diagnosis and Treatment was estimated at US$1.5 Billion in 2023 and is projected to reach US$2 Billion by 2030, growing at a CAGR of 4.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The Global Brain Tumor Diagnosis and Treatment Market is anticipated to experience steady growth, with the Primary Brain Tumor Diagnosis and Treatment segment projected to reach US$1.3 Billion by 2030 at a CAGR of 4.1%. Meanwhile, the Secondary Brain Tumor Diagnosis and Treatment segment is set to expand at a faster rate of 4.8% CAGR over the next seven years.

Regional insights reveal the U.S. market, valued at $399.7 Million in 2023, as a key player, while China is forecasted to grow impressively at a 7.7% CAGR, reaching $455.1 Million by 2030. Other regions, including Japan, Canada, Germany, and the Asia-Pacific, also exhibit promising growth trends.

The report provides comprehensive market data, featuring independent analysis of annual sales and forecasts in US$ Million from 2023 to 2030. Detailed regional analysis covers major markets globally, including North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. It also includes profiles of leading companies such as AstraZeneca PLC, Carestream Health, Inc., and GE Healthcare, offering insights into their market presence and strategies. Complimentary updates are available for one year, ensuring access to the latest market developments.

Key Questions Answered:

  • How is the Global Brain Tumor Diagnosis and Treatment Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Key Attributes:

Report Attribute Details
No. of Pages 173
Forecast Period 2023 – 2030
Estimated Market Value (USD) in 2023 $1.5 Billion
Forecasted Market Value (USD) by 2030 $2 Billion
Compound Annual Growth Rate 4.3%
Regions Covered Global

Key Topics Covered:

MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Brain Tumor Diagnosis and Treatment – Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

MARKET TRENDS & DRIVERS

  • Rising Prevalence of Brain Tumors Driving Demand for Diagnostic and Treatment Solutions
  • Technological Advancements in MRI and CT Imaging for Early Tumor Detection
  • Growth in Targeted Therapy and Immunotherapy Applications for Brain Tumor Treatment
  • Increasing Adoption of AI and Machine Learning for Accurate Tumor Diagnosis
  • Expansion of Minimally Invasive Surgical Techniques in Brain Tumor Removal
  • Impact of Personalized Medicine and Genomic Studies on Treatment Strategies
  • Rising Investments in Research for Developing Advanced Diagnostic Tools
  • Growing Use of Radiotherapy and Radiosurgery in Brain Tumor Management
  • Development of Innovative Drug Delivery Systems for Brain Tumor Treatment
  • Emergence of Liquid Biopsy Techniques for Non-Invasive Diagnosis
  • Increasing Focus on Clinical Trials and Approvals for Novel Therapeutics
  • Impact of Healthcare Infrastructure Development in Emerging Markets on Accessibility

FOCUS ON SELECT PLAYERSS (Total 42 Featured):

  • AstraZeneca PLC
  • Carestream Health, Inc.
  • GE Healthcare
  • Hitachi Medical Corporation
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

For more information about this report visit https://www.researchandmarkets.com/r/tzxn8g

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Brain Tumor Diagnosis and Treatment Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Every AI Agent Needs a Kill Switch: DigiCert Launches AI Trust Manager

The Royal Society of Canada Announces its 2026 Award Winners

OpenEye and CENTEGIX Integrate Live Video and Emergency Alerts to Accelerate Incident Response

ClassOne Technology Secures Multi-System Follow-on Orders from Top Photonics Manufacturers for High-Volume 6-inch InP Gold Plating

UNSW Delegation Visits COFE+ 7th-Generation Robotic Café in Shanghai, Exploring the Future of AI-Powered Coffee Retail

Cashu Research Updates Victory Metals (ASX: VTM) Coverage as Mining Lease Lands

Maxi Yacht Rolex Cup 2026. Rolex IMA Maxi 1 & Maxi Grand Prix World Championship

AI Vector Graphics Tools Power Creative Workflows in CorelDRAW Graphics Suite 2026

Brandon Hall Group Publishes New Bellwether Report on the Future of Financial Wellness

Editors Picks

The Royal Society of Canada Announces its 2026 Award Winners

September 15, 2026

OpenEye and CENTEGIX Integrate Live Video and Emergency Alerts to Accelerate Incident Response

September 15, 2026

ClassOne Technology Secures Multi-System Follow-on Orders from Top Photonics Manufacturers for High-Volume 6-inch InP Gold Plating

September 15, 2026

UNSW Delegation Visits COFE+ 7th-Generation Robotic Café in Shanghai, Exploring the Future of AI-Powered Coffee Retail

September 15, 2026

Latest News

Cashu Research Updates Victory Metals (ASX: VTM) Coverage as Mining Lease Lands

September 15, 2026

New Ontario rental rules change next week. What you should know

September 15, 2026

Maxi Yacht Rolex Cup 2026. Rolex IMA Maxi 1 & Maxi Grand Prix World Championship

September 15, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version